Disease areas:
  • bones, joints and muscles
Last updated:
Author(s):
Arjan P Bergink, Katerina Trajanoska, André G Uitterlinden, Joyce B J van Meurs
Publish date:
23 November 2020
Journal:
Rheumatology
PubMed ID:
33463692

Abstract

OBJECTIVE: The role of vitamin D in OA is unclear and previous epidemiological studies have provided inconsistent results. We conducted a two-sample Mendelian randomization (MR) study to investigate the causal relationship between genetically determined serum vitamin D levels and hip/knee OA.

METHODS: Six single-nucleotide polymorphisms (SNPs) associated with vitamin D levels in the Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits Consortium were selected as instrumental variables. Summary statistics of the SNPs effects on OA were derived from the Iceland and UK Biobank, comprising 23 877 knee OA cases, 17 151 hip OA cases and >562 000 controls. The control samples match the OA cases in age, sex and county of origin.

RESULTS: The MR analyses showed no causal association between genetically determined vitamin D levels and knee OA [odds ratio (OR) 1.03 (95% CI 0.84, 1.26)] or hip OA [OR 1.06 (95% CI 0.83, 1.35)].

CONCLUSION: Genetic variations associated with low vitamin D serum levels are not associated with increased risk of hip or knee OA in community-dwelling older adults, suggesting that vitamin D levels are not causally linked to OA. It is therefore unlikely that vitamin D supplementation protects against hip or knee OA.

Related projects

Coronary heart disease (CHD) and heart attack is caused by a combination of inherited and lifestyle/environmental factors. 17,000 new cases of CHD are expected to…

Institution:
University of Leicester, Great Britain

All projects